Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica
The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia | PLOS ONE
Kaplan-Meier survival curves of event-free survival (EFS) and overall... | Download Scientific Diagram
Kaplan-Meier overall survival and event free survival curves of acute... | Download Scientific Diagram
Cancers | Free Full-Text | Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study
First Randomized Trial to Show Benefit of Tyrosine Kinase Inhibitor in Newly Diagnosed Acute Myeloid Leukemia - The ASCO Post
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study | Leukemia
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy | Haematologica
A) Overall survival and (B) event-free survival for the subgroup of... | Download Scientific Diagram
Cureus | Absolute Lymphocyte Count at Day 28 Independently Predicts Event- Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE
Figure 3 from Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. | Semantic Scholar
Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study - ScienceDirect
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital | NEJM
Single‑cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction
Acute Lymphoblastic Leukemia | NEJM
Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute myeloid leukemia
Overall survival and event-free survival according to primary... | Download Scientific Diagram
